Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1960 1
1961 1
1965 1
1970 1
1971 1
1975 3
1977 2
1978 3
1979 2
1980 5
1981 2
1982 2
1983 9
1984 1
1985 2
1986 6
1987 1
1988 15
1989 11
1990 12
1991 4
1992 14
1993 11
1994 12
1995 20
1996 22
1997 20
1998 22
1999 16
2000 11
2001 10
2002 26
2003 22
2004 31
2005 20
2006 15
2007 19
2008 11
2009 18
2010 14
2011 8
2012 21
2013 17
2014 18
2015 18
2016 19
2017 10
2018 11
2019 11
2020 13
2021 23
2022 16
2023 27
2024 24
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

636 results

Results by year

Filters applied: . Clear all
Page 1
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.
Mitani K, Lee JW, Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Murotani K, Shimizu M, Matsuda A, Ozawa K, Nakao S. Mitani K, et al. Blood Adv. 2024 Mar 26;8(6):1415-1419. doi: 10.1182/bloodadvances.2023010959. Blood Adv. 2024. PMID: 38134300 Free PMC article. Clinical Trial. No abstract available.
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Enokitani K, Matsuda A, Ozawa K, Mitani K, Lee JW, Nakao S. Jang JH, et al. Among authors: mitani k. Br J Haematol. 2021 Jan;192(1):190-199. doi: 10.1111/bjh.17190. Epub 2020 Nov 5. Br J Haematol. 2021. PMID: 33152120 Free PMC article. Clinical Trial.
[Ⅰ.Myelodysplastic Syndromes].
Ichikawa M, Mitani K. Ichikawa M, et al. Among authors: mitani k. Gan To Kagaku Ryoho. 2019 May;46(5):862-867. Gan To Kagaku Ryoho. 2019. PMID: 31189805 Japanese. No abstract available.
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.
Ikoma Y, Nakamura N, Kaneda Y, Takamori H, Seki T, Hiramoto N, Kitagawa J, Kanda J, Fujita K, Morishita T, Ochi Y, Chiba S, Sasaki N, Ichii M, Imada K, Watanabe M, Hishizawa M, Miyahara Y, Maesako Y, Tanaka Y, Oka S, Tsuji M, Yoshihara S, Mitani K, Ueda Y, Kitano T, Watanabe M, Sezaki N, Kondo T, Kasahara S, Takaori-Kondo A, Kanemura N, Ogawa S, Nannya Y. Ikoma Y, et al. Among authors: mitani k. Leukemia. 2025 Jun;39(6):1362-1367. doi: 10.1038/s41375-025-02625-3. Epub 2025 Apr 21. Leukemia. 2025. PMID: 40259101 Free PMC article.
Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10).
Okuda R, Ochi Y, Saiki R, Yamanaka T, Terao C, Yoshizato T, Nakagawa MM, Zhao L, Ohyashiki K, Hiramoto N, Sanada M, Handa H, Kasahara S, Miyazaki Y, Sezaki N, Shih LY, Kern W, Kanemura N, Kitano T, Imashuku S, Watanabe M, Creignou M, Chonabayashi K, Usuki K, Ishikawa T, Gotoh A, Atsuta Y, Shiraishi Y, Mitani K, Chiba S, Takaori-Kondo A, Miyano S, Kamatani Y, Haferlach T, Hellström-Lindberg E, Matsuda K, Yoshida Y, Makishima H, Nannya Y, Ogawa S. Okuda R, et al. Among authors: mitani k. Leukemia. 2025 Mar;39(3):760-764. doi: 10.1038/s41375-024-02494-2. Epub 2024 Dec 23. Leukemia. 2025. PMID: 39715854 Free PMC article. No abstract available.
[Myelodysplastic syndrome].
Mitani K. Mitani K. Nihon Rinsho. 2008 Mar;66(3):513-9. Nihon Rinsho. 2008. PMID: 18330027 Review. Japanese.
Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction.
Otsuka Y, Imamura K, Oishi A, Asakawa K, Kondo T, Nakai R, Suga M, Inoue I, Sagara Y, Tsukita K, Teranaka K, Nishimura Y, Watanabe A, Umeyama K, Okushima N, Mitani K, Nagashima H, Kawakami K, Muguruma K, Tsujikawa A, Inoue H. Otsuka Y, et al. Among authors: mitani k. JCI Insight. 2024 Apr 22;9(8):e174179. doi: 10.1172/jci.insight.174179. JCI Insight. 2024. PMID: 38646933 Free PMC article.
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.
Lee JW, Jang JH, Yamazaki H, Sawa M, Kizaki M, Tomiyama Y, Nagafuji K, Usuki K, Gau JP, Morita Y, Tang JL, Chang H, Noshiro M, Matsuda A, Ozawa K, Mitani K, Kanda Y, Nakao S. Lee JW, et al. Among authors: mitani k. Blood Adv. 2025 Aug 4:bloodadvances.2024014855. doi: 10.1182/bloodadvances.2024014855. Online ahead of print. Blood Adv. 2025. PMID: 40758947 No abstract available.
Lymphangioleiomyomatosis in a Male.
Wakida K, Watanabe Y, Kumasaka T, Seyama K, Mitani K, Hiraki T, Kamimura G, Nagata T, Nakamura Y, Sato M. Wakida K, et al. Among authors: mitani k. Ann Thorac Surg. 2015 Sep;100(3):1105-7. doi: 10.1016/j.athoracsur.2014.11.069. Ann Thorac Surg. 2015. PMID: 26354644
Progress toward human gene therapy.
Morsy MA, Mitani K, Clemens P, Caskey CT. Morsy MA, et al. Among authors: mitani k. JAMA. 1993 Nov 17;270(19):2338-45. JAMA. 1993. PMID: 8230597 Review. No abstract available.
636 results